Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-α

International Journal of Oncology

Volumn 14, Issue 2, 1999, Pages 291-300

  Rao, Velidi H ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Giant cell tumor of bone; Matrix metalloproteinase; Tumor necrosis factor

Indexed keywords

COLLAGENASE; GELATINASE B; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BIOSYNTHESIS; BONE TUMOR; CASE REPORT; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; OSTEOCLASTOMA; PATHOLOGY; STROMA CELL; TRANSACTIVATION;

ADULT; BONE NEOPLASMS; COLLAGENASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GIANT CELL TUMOR OF BONE; HUMANS; MATRIX METALLOPROTEINASE 9; STROMAL CELLS; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033070929     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Huvos A Bone Tumors: Diagnosis, Treatment and Prognosis. Huvos A (ed). WB Sanders Co, Philadelphia, pp429-467, 1991.
2. Tubbs WS, Brown LR, Beabout JW, Rock MG and Unni KK: Benign giant cell tumor of bone with pulmonary metastases: clinical finding and radiologic appearance of metastases in 13 cases. Am J Roentgenol 158: 331-334, 1992.
3. Komiya S, Inoue A, Nakashima M, Ueno A, Fujikawa K and Ikuta H: Prognostic factors in giant cell tumor of bone: a modified histological grading system useful as a guide to prognosis. Arch Orthop Trauma Surg 105: 67-72, 1986.
4. Liotta LA and Stettier-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51(Suppl.): 5054S-5059S, 1991.
5. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145-2154, 1991.
6. Freije JMP, Diez-Itaza CJ, Balbin M, Sanchez LM, Blasco R, Tolova J and Lopez-Otin C: Molecular cloning of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269: 16766-16773, 1994.
7. Knauper V, Lopez-Otin C, Smith B, Knight G and Murphy G: Biochemical characterization of human collagenase-3. J Biol Chem 271: 10917-10923, 1996.
8. Murphy G, Cocket MI, Ward RV and Docherty AJP: Matrix metalloproteinase degradation of elastin, type IV collagenase and proteoglycan: a quantitative comparision of activities of 95 kD and 75 kD truncated metalloprotenase (PUMP). Biochem J 277: 277-279, 1991.
9. Kinishita T, Sato H, Takino T, Itoh M, Akizawa J and Seiki M: Processing of precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. Cancer Res 56: 2535-2538, 1996.
10. Will H and Hinzmann B: cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmcmbrane segment. Eur J Biochem 231: 602-608, 1995.
11. Takino T, Sato H, Shinagawa A and Seiki M: Identification of the second membrane-type matrix metalloproteinase (MT-MMP) gene from a human placenta cDNA library. J Biol Chem 270: 23013-23030, 1995.